Rugnath Renira, Orzechowicz Casey, Newell Clayton, Carullo Veronica, Rugnath Anesh
Department and Anesthesiology, University of Mississippi Medical Center, Jackson, MS 39216, USA.
Biomedicines. 2024 Jan 17;12(1):204. doi: 10.3390/biomedicines12010204.
Classically, neuropathic pain is described as a pain caused by a lesion or disease of the somatosensory system. However, one must note that the presence of somatosensory pathology alone does not guarantee a progression to neuropathic pain. This is due, in part, to the fact that neuropathic pain is a notoriously complex disease process, involving sensitization of both the central and peripheral nervous systems. Its causes are also numerous and varied, including trauma, the compression of a nerve, autoimmune disorders, diabetes, and infections. Due to the various manifestations, causes, and symptoms of neuropathic pain, the treatment of this disease process has proved challenging for generations of physicians. This section aims to elaborate on newly proposed mechanisms for pharmacological and targeted therapies, such as neurostimulation, which aim to reduce the negative somatosensory effects of neuropathic pain.
传统上,神经性疼痛被描述为由躯体感觉系统的损伤或疾病引起的疼痛。然而,必须注意的是,仅存在躯体感觉病理学改变并不能保证发展为神经性疼痛。部分原因在于,神经性疼痛是一个极其复杂的疾病过程,涉及中枢和外周神经系统的敏化。其病因也多种多样,包括创伤、神经受压、自身免疫性疾病、糖尿病和感染。由于神经性疼痛的各种表现、病因和症状,历代医生都证明对这种疾病过程的治疗具有挑战性。本节旨在详细阐述新提出的药物治疗和靶向治疗机制,如神经刺激,旨在减轻神经性疼痛的负面躯体感觉效应。